54. Viral Mutation

1. Introduction

Viral mutation is one of the fundamental mechanisms responsible for genetic diversity, adaptation, immune escape, antiviral resistance, and viral evolution.

Viruses undergo mutations when changes occur in their genetic material during genome replication or through other molecular processes. These changes may alter viral proteins, replication efficiency, host range, tissue tropism, antigenicity, or susceptibility to antiviral drugs.

Mutation is particularly important in RNA viruses because many RNA-dependent RNA polymerases lack efficient proofreading activity. However, mutation rates differ substantially between viruses, and some RNA viruses possess proofreading mechanisms. DNA viruses also undergo mutations, while retroviruses accumulate genetic changes through reverse transcription and other processes.

Viral mutations can be neutral, deleterious, or advantageous in a particular environment. Importantly, a mutation does not automatically make a virus more dangerous. Its effect depends on the genetic change, the viral background, the host, and the environment in which the virus replicates.

2. Definition

A viral mutation is a heritable change in the nucleotide sequence of a viral genome.

Mutations may arise through errors during genome replication, chemical damage to nucleic acids, host-mediated editing, recombination-associated processes, or other mechanisms.

A mutation can affect a single nucleotide or involve a larger genomic region. Its consequences depend on whether it changes a protein-coding sequence, a regulatory element, a replication signal, or another functional region of the genome.

3. Why are mutations important in virology?

Viral mutations have several major biological and clinical consequences.

• Genetic diversity: Generate variation within viral populations.

• Antigenic change: May alter epitopes recognized by antibodies or immune cells.

• Antiviral resistance: May reduce susceptibility to antiviral drugs.

• Host adaptation: May influence the ability to replicate in different hosts or cell types.

• Altered pathogenicity: May increase, decrease, or otherwise change disease-causing potential.

• Diagnostic implications: Mutations in assay-targeted regions may affect the performance of some molecular tests.

• Vaccine implications: Mutations can alter immune recognition, although their impact depends on the vaccine, pathogen, and immune response.

• Evolution: Provide genetic variation upon which natural selection and other evolutionary processes act.

Not every mutation becomes established in a viral population. Many mutations disappear because they impair replication, confer no advantage, or occur in lineages that fail to transmit.

4. Mechanisms of viral mutation

4.1 Errors during genome replication

The most important source of many viral mutations is nucleotide misincorporation during genome synthesis.

During replication, a viral polymerase adds nucleotides to a growing nucleic acid strand. An incorrect nucleotide may occasionally be incorporated.

If the error is not corrected, it can become a permanent sequence change in subsequent replication cycles.

The accuracy of replication depends on:

• Polymerase structure and fidelity.

• Proofreading activity.

• Availability and balance of nucleotides.

• Genome structure.

• Replication conditions.

• Host-cell factors.

4.2 RNA-dependent RNA polymerase

RNA viruses generally use an RNA-dependent RNA polymerase to synthesize RNA from an RNA template.

Many RNA-dependent RNA polymerases have limited proofreading capacity, resulting in comparatively high mutation rates.

However, this is not universal. Coronaviruses, for example, possess a proofreading-associated exonuclease that improves replication fidelity relative to many other RNA viruses.

4.3 DNA-dependent DNA polymerase

DNA viruses replicate their genomes using viral or host DNA polymerases, depending on the virus.

Many DNA polymerases possess proofreading activity, and cellular DNA repair pathways may further reduce the persistence of replication errors.

Consequently, many DNA viruses have lower mutation rates than many RNA viruses, although there is considerable variation across viral families.

4.4 Reverse transcriptase

Retroviruses use reverse transcriptase to synthesize DNA from an RNA template.

Reverse transcriptase is error-prone and lacks the conventional proofreading activity found in many high-fidelity DNA polymerases.

In HIV, this contributes to extensive genetic diversity, immune escape, and the emergence of antiviral resistance.

4.5 Host-mediated RNA editing

Host enzymes can modify viral nucleic acids.

Examples include:

• APOBEC-family cytidine deaminases: Can introduce characteristic nucleotide changes into susceptible viral genomes.

• ADAR enzymes: Convert adenosine to inosine in double-stranded RNA regions, potentially altering RNA sequences and recognition.

These processes may inhibit viral replication, produce mutations, or generate defective genomes. Their effects depend on the virus and the cellular context.

4.6 Chemical and physical damage

Nucleic acids can be damaged by reactive chemicals, oxidative stress, ultraviolet radiation, and other environmental or intracellular factors.

If damaged bases are copied during replication without accurate repair, mutations may result.

5. Types of viral mutation

Viral mutations can be classified according to the scale of the genetic change and its effect on the genome or encoded product.

5.1 Point mutation

A point mutation involves a change at a single nucleotide position.

Point mutations include substitutions, and the term is sometimes used more broadly for small changes affecting one nucleotide.

A substitution may change a codon, affect a regulatory sequence, or have no measurable biological consequence.

5.2 Nucleotide substitution

A nucleotide substitution occurs when one nucleotide is replaced by another.

Substitutions are often classified as transitions or transversions.

Transition: A purine is replaced by another purine, or a pyrimidine by another pyrimidine.

• Purine: adenine (A), guanine (G).

• Pyrimidine: cytosine (C), thymine (T), or uracil (U) in RNA.

Transversion: A purine is replaced by a pyrimidine, or vice versa.

Neither class is inherently always more harmful. The consequence depends on the position and functional context of the mutation.

5.3 Insertion

An insertion occurs when one or more nucleotides are added to a genome.

An insertion within a protein-coding region can alter the reading frame if the number of inserted nucleotides is not a multiple of three.

Insertions may also affect non-coding regulatory regions or genome-length constraints.

5.4 Deletion

A deletion involves the loss of one or more nucleotides.

Depending on the location and size of the deletion, it may:

• Remove amino acids from a protein.

• Disrupt a reading frame.

• Alter RNA structures.

• Remove regulatory signals.

• Produce a defective genome.

Large deletions may substantially impair replication or eliminate an essential viral function.

5.5 Frameshift mutation

A frameshift occurs when an insertion or deletion changes the reading frame of a protein-coding sequence.

For example, insertion or deletion of one nucleotide changes how downstream nucleotides are grouped into codons.

Frameshifts can produce extensive changes in the amino acid sequence and may introduce premature stop codons.

Insertions or deletions in multiples of three nucleotides generally preserve the reading frame, although they can still have important functional effects.

5.6 Synonymous mutation

A synonymous mutation changes a codon without changing the encoded amino acid.

This occurs because the genetic code is degenerate: multiple codons can encode the same amino acid.

Synonymous mutations are not necessarily biologically neutral. They may affect:

• RNA secondary structure.

• RNA stability.

• Translation efficiency.

• Codon usage.

• Splicing or other RNA-processing signals, where applicable.

5.7 Nonsynonymous mutation

A nonsynonymous mutation changes the encoded amino acid.

It may be classified as:

• Missense: One amino acid is replaced by another.

• Nonsense: A codon is changed into a premature stop codon.

A missense mutation may alter protein folding, receptor binding, enzymatic activity, immune recognition, or drug susceptibility. Its effect may be negligible, harmful, or advantageous depending on the context.

5.8 Regulatory mutations

Mutations in non-coding regions may affect:

• Promoters and transcriptional control elements.

• RNA replication signals.

• RNA secondary structures.

• Genome packaging signals.

• Translation initiation or regulation.

• Genome stability.

These mutations can influence viral replication even when no amino acid sequence changes.

5.9 Lethal and conditional mutations

A lethal mutation prevents the virus from completing a productive replication cycle under the relevant conditions.

A conditional mutation produces a phenotype under particular conditions but may permit replication under others.

Temperature-sensitive viral mutants are a classic experimental example: a mutant may replicate at a permissive temperature but show impaired replication at a restrictive temperature.

6. Effects of mutations on viral fitness

Viral fitness describes the ability of a viral genotype to survive and reproduce in a particular environment.

Mutations may have three broad categories of effects.

6.1 Beneficial mutations

A mutation may improve replication or transmission under specific conditions.

Examples include mutations that, in a particular viral background, reduce susceptibility to an antiviral drug or improve escape from an existing antibody response.

A mutation that is advantageous in one environment may be neutral or harmful in another.

6.2 Deleterious mutations

A deleterious mutation reduces viral fitness.

It may disrupt an essential protein, impair genome replication, interfere with particle assembly, or prevent successful transmission.

Many newly arising mutations fall into this category.

6.3 Neutral mutations

A neutral mutation has little or no measurable effect on viral fitness under the conditions being studied.

Neutral mutations can accumulate and become useful markers for tracking viral lineages.

However, an apparently neutral mutation under one experimental condition may have a different effect in another host or environment.

7. Mutation rate versus mutation frequency

These terms describe different concepts and should not be used interchangeably.

Mutation rate refers to the frequency at which new mutations arise during replication, expressed according to a defined unit such as per nucleotide copied or per genome replication.

Mutation frequency refers to the proportion of a population carrying a particular mutation at a given time.

Mutation frequency is influenced not only by mutation rate but also by selection, genetic drift, population size, transmission bottlenecks, and the history of the viral population.

A mutation may arise frequently but remain rare because it is deleterious. Conversely, a mutation that arises rarely may become common if it provides a substantial advantage or spreads through a successful lineage.

8. Viral mutation and antigenic change

Mutations can alter viral antigens, particularly surface proteins targeted by antibodies.

If a mutation changes an antibody-binding epitope without severely impairing viral function, the resulting variant may partially evade pre-existing antibody responses.

This process can contribute to antigenic variation.

Examples include:

• Mutations in influenza haemagglutinin and neuraminidase.

• Changes in the SARS-CoV-2 spike protein.

• Mutations in HIV envelope glycoproteins.

However, antigenic variation is broader than mutation alone. Recombination, reassortment, changes in glycosylation, and other mechanisms can also influence immune recognition.

9. Viral mutation and antiviral resistance

Antiviral drugs impose selective pressure on viral populations.

If a viral population contains, or generates, variants that replicate more successfully in the presence of a drug, these variants may increase in frequency during treatment.

Mechanisms of resistance

Mutations may:

• Reduce drug binding to a viral enzyme.

• Alter the active site of a drug target.

• Change the function of a viral protein involved in drug activation.

• Compensate for the fitness cost of another resistance mutation.

• Alter drug entry or other steps in the viral life cycle.

Clinical examples

HIV: Mutations in reverse transcriptase, protease, integrase, or other relevant targets can contribute to resistance against particular antiretroviral drugs.

Influenza: Mutations in neuraminidase can reduce susceptibility to specific neuraminidase inhibitors.

Hepatitis B virus: Mutations in the viral polymerase can contribute to resistance against particular nucleos(t)ide analogues.

Hepatitis C virus: Resistance-associated substitutions may affect susceptibility to particular direct-acting antivirals.

Resistance interpretation is drug-specific. The presence of a mutation does not automatically establish clinical treatment failure; viral background, drug exposure, adherence, and the resistance profile all matter.

10. Mutation and viral evolution

Mutation generates new genetic variation, but mutation alone does not explain viral evolution.

Viral evolution is shaped by several interacting processes:

• Mutation.

• Natural selection.

• Genetic drift.

• Recombination.

• Reassortment in viruses with segmented genomes.

• Population bottlenecks.

• Migration and transmission patterns.

Mutations provide raw genetic variation. Selection changes the relative success of variants according to their biological effects in a given environment.

For example, a mutation that reduces susceptibility to an antiviral drug may become more common during treatment if the virus can still replicate effectively.

By contrast, a mutation that impairs an essential viral protein may disappear because the affected virus is less capable of reproducing or transmitting.

11. Mutation in RNA viruses versus DNA viruses

These are general trends, not absolute rules. Mutation rates must be compared using the same measurement method and biological context.

12. Mutation, quasispecies, and population diversity

Many RNA viruses exist as populations of related but non-identical genomes.

The term quasispecies describes a dynamic distribution of related genetic variants generated by mutation and shaped by selection and other population processes.

Within such a population, a particular mutation may be present at low frequency before becoming dominant under changing conditions.

For example, antiviral treatment may select a resistant variant that was previously rare or that arose during ongoing replication.

Not every viral population should automatically be described as a quasispecies in the strict population-genetic sense. The term is most useful when referring to a distribution of related variants subject to mutation and selection.

13. Mutation versus recombination and reassortment

These processes all generate viral genetic variation, but they are mechanistically different.

Mutation changes the sequence of a genome. Recombination changes how genetic material is joined, and reassortment exchanges complete genome segments.

Complementation and phenotypic mixing can alter viral phenotype without necessarily creating a permanent change in the viral genome.

14. Detection and characterization of viral mutations

Viral mutations are detected through molecular methods that identify and compare nucleotide sequences.

14.1 Targeted PCR and sequencing

Specific genomic regions can be amplified and sequenced to identify mutations associated with resistance, genotyping, or other clinically relevant properties.

The method is useful when the genomic region of interest is already known.

14.2 Sanger sequencing

Sanger sequencing is useful for analysing individual genomic regions and identifying dominant sequence variants.

Its sensitivity for low-frequency minority variants is limited compared with appropriately designed deep-sequencing approaches.

14.3 Next-generation sequencing

Next-generation sequencing can characterize large portions of a viral genome or the entire genome.

Depending on the assay, it can identify:

• Single-nucleotide substitutions.

• Insertions and deletions.

• Mixed viral populations.

• Minority variants.

• Recombination-associated patterns, with suitable analysis.

• Mutations relevant to antiviral resistance.

Interpretation depends on sequencing depth, error rates, sample quality, and the bioinformatics pipeline.

14.4 Whole-genome sequencing

Whole-genome sequencing provides a broader view of genetic variation across the viral genome.

It is valuable for phylogenetic analysis, outbreak investigation, lineage assignment, and the identification of mutations outside predefined target regions.

14.5 Limitations

• Sequencing detects genetic differences but does not automatically establish their biological significance.

• A mutation may be a lineage marker rather than a functional adaptation.

• Mixed populations may be missed if the assay lacks adequate sensitivity.

• Mutations in primer or probe binding regions can compromise some molecular assays.

• Functional experiments or clinical evidence may be required to establish the effect of a mutation.

15. Common misconceptions

Misconception 1: Every viral mutation is harmful.

Incorrect. Mutations may be beneficial, deleterious, or neutral depending on the context.

Misconception 2: All RNA viruses mutate faster than all DNA viruses.

Incorrect. Many RNA viruses have high mutation rates, but replication fidelity varies considerably across viral families.

Misconception 3: A mutation automatically creates a new viral variant of public health concern.

Incorrect. A mutation may have little biological effect. Its significance depends on functional evidence, epidemiological patterns, and other characteristics.

Misconception 4: Mutation and genetic drift mean the same thing.

Incorrect. Mutation generates new genetic changes; genetic drift changes variant frequencies through stochastic processes.

Misconception 5: Antiviral resistance always develops because treatment directly causes a specific mutation.

Incorrect. Treatment generally selects resistant variants that arise or were already present. The probability and outcome depend on viral replication, genetic diversity, and the drug regimen.

Misconception 6: Sequencing a mutation proves that it causes increased virulence.

Incorrect. Sequence association alone does not establish causality. Functional and epidemiological evidence may be necessary.

16. High-yield examination points

• A viral mutation is a heritable change in the viral nucleotide sequence.

• Mutations arise through replication errors, nucleic acid damage, host-mediated editing, and other processes.

• Transitions involve purine-to-purine or pyrimidine-to-pyrimidine substitutions.

• Transversions involve purine-to-pyrimidine or pyrimidine-to-purine substitutions.

• Synonymous mutations do not change the encoded amino acid but may still affect viral biology.

• Nonsynonymous mutations alter the encoded amino acid sequence.

• Insertions and deletions can cause frameshifts when the change is not a multiple of three nucleotides in a coding region.

• Many RNA viruses have relatively high mutation rates, but this is not universal.

• HIV diversity is influenced by error-prone reverse transcription and rapid replication.

• Mutation provides genetic variation; natural selection and genetic drift influence variant frequencies.

• Antiviral resistance can emerge through selection of mutations affecting drug targets or related processes.

• Sequencing detects mutations, but functional significance requires careful interpretation.

• Mutation is distinct from recombination, reassortment, complementation, and phenotypic mixing.

17. Take-home message

Viral mutation is a fundamental source of genetic variation. It allows viral populations to generate new genotypes, some of which may affect immune recognition, drug susceptibility, host adaptation, or replication.

However, mutations do not inevitably make viruses more virulent or transmissible. Their effects depend on the specific change, genetic background, host environment, and evolutionary pressures acting on the viral population.

For clinical microbiology, the most important applications are understanding antiviral resistance, interpreting genomic surveillance, tracking viral evolution, and distinguishing a detected mutation from a mutation with proven clinical significance.

18. Standard references

1. Knipe DM, Howley PM, editors. Fields Virology. Wolters Kluwer. Consult sections on viral genetics, mutation, replication fidelity, and evolution.

2. Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW. Principles of Virology. ASM Press. Consult sections on viral genetics, genetic variation, and evolutionary processes.

3. Domingo E, Perales C. Viral quasispecies. PLoS Genetics. 2019;15(10).

4. Sanjuán R, Domingo-Calap P. Mechanisms of viral mutation. Cellular and Molecular Life Sciences. 2016;73:4433–4448.

5. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Elsevier. Consult the chapters on viral replication, pathogenesis, and antiviral resistance.

6. Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Elsevier. Consult the relevant virus-specific chapters on genetic variation and antiviral resistance.